Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Trabaud

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Journal of Clinical Microbiology|May 1, 1997
Development of a reverse transcriptase PCR-enzyme-linked immunosorbent assay for quantification of human immunodeficiency virus type 1 RNA in plasma: comparison with commercial quantitative assaysM A Trabaud, G Audoly, K Leriche, et al.
Gastroenterologie Clinique Et Biologique|September 22, 2009
Sexually transmitted HCV infection and reinfection in HIV-infected homosexual menL Cotte, P Chevallier Queyron, I Schlienger, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 14, 1997
Correlation between antiretroviral resistance mutations, biological parameters, and clinical evolution in zidovudine-treated patients infected with human immunodeficiency virus type 1K Leriche-Guérin, M A Trabaud, L Cotte, et al.
Journal of Medical Virology|May 1, 1997
Comparison of HCV RNA assays for the detection and quantification of hepatitis C virus RNA levels in serum of patients with chronic hepatitis C treated with interferonM A Trabaud, F Bailly, S N Si-Ahmed, et al.
The Journal of Hospital Infection|December 24, 2002
The risk of hospital-acquired GB virus C infection: a pilot case-control studyP Vanhems, N Voirin, C Trépo, et al.
Journal of Medical Virology|June 22, 2000
Prevalence of primary resistance to zidovudine and lamivudine in drug-naive human immunodeficiency virus type-1 infected patients: high proportion of reverse transcriptase codon 215 mutant in circulating lymphocytes and free virusM A Trabaud, K Leriche-Guerin, C Regis, et al.
Journal of Viral Hepatitis|March 4, 2010
Proficiency of transient elastography compared to liver biopsy for the assessment of fibrosis in HIV/HBV-coinfected patientsP Miailhes, P Pradat, M Chevallier, et al.
Journal of Medical Virology|June 29, 2007
Occult HBV infection may represent a major risk factor of non-response to antiviral therapy of chronic hepatitis CS Mrani, I Chemin, K Menouar, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society|January 23, 1999
Investigations into the cross-reactivity of rabbit antibodies raised against nonhomologous pairs of synthetic peptides derived from HIV-1 gp120 proteinsV Krsmanovic, J M Biquard, M Sikorska-Walker, et al.
Journal of Medical Virology|November 26, 1998
HCV core immunodominant region analysis using mouse monoclonal antibodies and human sera: characterization of major epitopes useful for antigen detectionC Jolivet-Reynaud, P Dalbon, F Viola, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal of Clinical Microbiology|May 1, 1997
Development of a reverse transcriptase PCR-enzyme-linked immunosorbent assay for quantification of human immunodeficiency virus type 1 RNA in plasma: comparison with commercial quantitative assaysM A Trabaud, G Audoly, K Leriche, et al.
Gastroenterologie Clinique Et Biologique|September 22, 2009
Sexually transmitted HCV infection and reinfection in HIV-infected homosexual menL Cotte, P Chevallier Queyron, I Schlienger, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 14, 1997
Correlation between antiretroviral resistance mutations, biological parameters, and clinical evolution in zidovudine-treated patients infected with human immunodeficiency virus type 1K Leriche-Guérin, M A Trabaud, L Cotte, et al.
Journal of Medical Virology|May 1, 1997
Comparison of HCV RNA assays for the detection and quantification of hepatitis C virus RNA levels in serum of patients with chronic hepatitis C treated with interferonM A Trabaud, F Bailly, S N Si-Ahmed, et al.
The Journal of Hospital Infection|December 24, 2002
The risk of hospital-acquired GB virus C infection: a pilot case-control studyP Vanhems, N Voirin, C Trépo, et al.
Journal of Medical Virology|June 22, 2000
Prevalence of primary resistance to zidovudine and lamivudine in drug-naive human immunodeficiency virus type-1 infected patients: high proportion of reverse transcriptase codon 215 mutant in circulating lymphocytes and free virusM A Trabaud, K Leriche-Guerin, C Regis, et al.
Journal of Viral Hepatitis|March 4, 2010
Proficiency of transient elastography compared to liver biopsy for the assessment of fibrosis in HIV/HBV-coinfected patientsP Miailhes, P Pradat, M Chevallier, et al.
Journal of Medical Virology|June 29, 2007
Occult HBV infection may represent a major risk factor of non-response to antiviral therapy of chronic hepatitis CS Mrani, I Chemin, K Menouar, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society|January 23, 1999
Investigations into the cross-reactivity of rabbit antibodies raised against nonhomologous pairs of synthetic peptides derived from HIV-1 gp120 proteinsV Krsmanovic, J M Biquard, M Sikorska-Walker, et al.
Journal of Medical Virology|November 26, 1998
HCV core immunodominant region analysis using mouse monoclonal antibodies and human sera: characterization of major epitopes useful for antigen detectionC Jolivet-Reynaud, P Dalbon, F Viola, et al.
Pageof 3